USE OF CORE 2 GLCNAC TRANSFERASE INHIBITORS IN TREATING INFLAMMATION - Patent 1131334

(19)

(11)

EP 1 131 334 A1

(12)

(43)	Date of publication:
	12.09.2001 Bulletin 2001/37

(21)	Application number: 99959043.3

(22)	Date of filing: 20.11.1999

(51)	International Patent Classification (IPC)⁷: C07H 21/04, C07K 16/00, C12N 15/63, C12N 15/85, A61K 48/00

(86)	International application number:
	PCT/US9927/465

(87)	International publication number:
	WO 0031/109 (02.06.2000 Gazette 2000/22)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

21.11.1998 US 109416 P
21.12.1998 US 113679 P

(71)	Applicant: The Regents of the University of California
	Oakland, CA 94607-5200 (US)

(72)	Inventors:
	MARTH, Jamey, D. San Diego, CA 92122 (US) ELLIES, Leslie, G. La Jolla, CA 92037 (US)

(74)	Representative: Brasnett, Adrian Hugh et al
	Mewburn EllisYork House23 Kingsway London WC2B 6HP London WC2B 6HP (GB)

(54)	USE OF CORE 2 GLCNAC TRANSFERASE INHIBITORS IN TREATING INFLAMMATION